✦ LIBER ✦

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

✍ Scribed by Jin Young Kim; Young Rok Do; Keon Uk Park; Min Kyung Kim; Kyung Hee Lee; Sung Hwa Bae; Hun Mo Ryoo; Jin Ho Baek; Hong Suk Song

Publisher: Springer
Year: 2009
Tongue: English
Weight: 200 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1130-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine and cis

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

✍ Jeeyun Lee; Young-Hyuck Im; Eun Yoon Cho; Yong Sang Hong; Hyo Rak Lee; Hyo Song 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 268 KB

Randomized phase II trial of two differe

Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer

✍ Se Hoon Park; Soo Jin Choi; Sun Young Kyung; Chang Hyeok An; Sang Pyo Lee; Jeong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

A multi-center phase II study of S-1 plu

A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer

✍ Jae Jin Lee; Si-Young Kim; Hyun-Cheol Chung; Kyung-Hee Lee; Hong-Suk Song; Won-K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 355 KB

A phase II study of weekly irinotecan as

A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer

✍ Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osam 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

Doublet regimen of cisplatin plus doceta

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB